ACHE and Alzheimer disease: Furthermore, the alkaloid extracts of the three species will be evaluated in terms of bioactivity and inhibition of AChE and BuChE enzymes in order to identify possible species that could represent new sources of cholinesterase inhibitors for the palliative treatment of Alzheimer’s disease.